Current Issue
Commentary
Is Cellular Senescence of Dopaminergic Neurons the Cause of Local Inflammation in the Midbrain Observed in Parkinson’s Disease?
J Cell Immunol, 2020, 2, 201 - 204
Markus Riessland
[DOI No.: https://doi.org/10.33696/immunology.2.043]
Commentary
The Yin and the Yang of STAT1 Downstream of TLR4 Endocytosis: STAT1 beyond Interferon Signaling
J Cell Immunol, 2020, 2, 205 - 210
Hozaifa Metwally, Tadamitsu Kishimoto
[DOI No.: https://doi.org/10.33696/immunology.2.044]
Review Article
Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases
J Cell Immunol, 2020, 2, 211 - 219
Chongyang Zhang, Chen Yan
[DOI No.: https://doi.org/10.33696/immunology.2.045]
Commentary
Control of CD4 Helper and CD8 Cytotoxic T cell Differentiation
J Cell Immunol, 2020, 2, 220 - 226
Vibhuti P Dave
[DOI No.: https://doi.org/10.33696/immunology.2.046]
Commentary
Pro-survival Bcl-2 Proteins are Modifiers of MYC-VX-680 Synthetic Lethality
J Cell Immunol, 2020, 2, 227 - 232
Jing Zhang, Shenqiu Zhang, Qiong Shi, Dun Yang, Thaddeus D. Allen
[DOI No.: https://doi.org/10.33696/immunology.2.047]
Commentary
Culture nTAD: A New Avenue for Research in Late-stage Human Lung Development and Perinatal Lung Disease
J Cell Immunol, 2020, 2, 232 - 236
Hongmei Mou
[DOI No.: https://doi.org/10.33696/immunology.2.048]
Review Article
Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies
J Cell Immunol, 2020, 2, 237 - 244
Aixia Dou, Jing Fang
[DOI No.: https://doi.org/10.33696/immunology.2.049]
Commentary
Hypomagnesemia and Outcomes in Hematologic Malignancies
J Cell Immunol, 2020, 2, 245 - 249
Jennifer Gile , Joy Heimgartner, Gordon Ruan, M. Molly McMahon, Thomas Witzig
[DOI No.: https://doi.org/10.33696/immunology.2.050]
Commentary
Emerging Functions of ICAM-1 in Macrophage Efferocytosis and Wound Healing
J Cell Immunol, 2020, 2, 250 - 253
Prarthana J. Dalal, Ronen Sumagin
[DOI No.: https://doi.org/10.33696/immunology.2.051]
Short Communication
Juvenile-onset Systemic Lupus Erythematosus Accompanied by Secondary Thrombotic Microangiopathy
J Cell Immunol, 2020, 2, 254 - 258
Eriko Tanaka, Tomoya Kaneda, Yuko Akutsu, Toru Kanamori, Mariko Mouri, Masaaki Mori
[DOI No.: https://doi.org/10.33696/immunology.2.052]
Commentary
Sofosbuvir/Velpatasvir/Voxilaprevir for Previously DAAtreated Patients with Chronic Hepatitis C?
J Cell Immunol, 2020, 2, 259 - 264
Llaneras J, Riveiro-Barciela M, Esteban R, Buti M